betamethasone has been researched along with halobetasol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Korsukewitz, G; Mensing, H; Yawalkar, S | 1 |
| Schwerzmann, L; Yawalkar, SJ | 1 |
| Freer, JP; Kalb, RE; Krochmal, L; Siskin, SB; Watson, WA | 1 |
| Jin, PY; Liu, XQ; Shao, CG; Wang, HQ; Yawalkar, S; Ye, GY | 1 |
| Aeling, JL; Huff, L; Walsh, P; Weston, WL | 1 |
| Amin, S; Kashani-Sabet, M; Zackheim, HS | 1 |
| Hecker, D; Lebwohl, M; Worsley, J; Yueh, G | 1 |
| Katta, R | 1 |
| Frieden, IJ; Garzon, MC; Hawrot, A; Lucky, AW | 1 |
| Hansen, JB; Nyholm, N; Patel, DS; Swensen, AR; Veverka, KA; Wu, JJ | 1 |
| Ayyagari, R; Glick, B; Guerin, A; Jacobson, A; Joseph, G; Kircik, L; Lin, T | 1 |
2 review(s) available for betamethasone and halobetasol
| Article | Year |
|---|---|
Lichen planus.
Topics: Acitretin; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Diagnosis, Differential; Humans; Keratolytic Agents; Lichen Planus; Patient Education as Topic; Prednisone; PUVA Therapy; Risk Factors; Teaching Materials | 2000 |
Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.
Topics: Administration, Cutaneous; Betamethasone; Clobetasol; Extremities; Eye Neoplasms; Eyelids; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2005 |
3 trial(s) available for betamethasone and halobetasol
| Article | Year |
|---|---|
A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clobetasol; Double-Blind Method; Female; Germany; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Remission Induction; Vasoconstrictor Agents; Wound Healing | 1991 |
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Dermatitis, Atopic; Double-Blind Method; Female; Germany, West; Glucocorticoids; Humans; Male; Middle Aged; Patient Satisfaction; Remission Induction; Vasoconstrictor Agents | 1991 |
Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Psoriasis | 1993 |
7 other study(ies) available for betamethasone and halobetasol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The safety of halobetasol 0.05% ointment in the treatment of psoriasis.
Topics: 17-Hydroxycorticosteroids; Adult; Aged; Betamethasone; Clobetasol; Drug Evaluation; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Psoriasis; Time Factors | 1990 |
Treatment of localized vitiligo with ulobetasol cream.
Topics: Administration, Cutaneous; Betamethasone; Clobetasol; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Male; Ointments; Vitiligo | 1990 |
Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Betamethasone; Betamethasone Valerate; Clobetasol; Drug Administration Schedule; Female; Fluocinonide; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Occlusive Dressings; Prospective Studies; Remission Induction; Skin Neoplasms; Treatment Outcome; Triamcinolone Acetonide | 1998 |
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis | 2000 |
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matchi
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |
Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adju
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |